630 related articles for article (PubMed ID: 25708760)
1. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
2. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
[TBL] [Abstract][Full Text] [Related]
3. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
[TBL] [Abstract][Full Text] [Related]
4. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
5. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
[TBL] [Abstract][Full Text] [Related]
6. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
[TBL] [Abstract][Full Text] [Related]
7. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
9. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
[TBL] [Abstract][Full Text] [Related]
10. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects.
Wong MC; Lam TY; Tsoi KK; Hirai HW; Chan VC; Ching JY; Chan FK; Sung JJ
Gut; 2014 Jul; 63(7):1130-6. PubMed ID: 24045331
[TBL] [Abstract][Full Text] [Related]
11. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
[TBL] [Abstract][Full Text] [Related]
13. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
[TBL] [Abstract][Full Text] [Related]
15. Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test.
He XX; Yuan SY; Li WB; Yang H; Ji W; Wang ZQ; Hao JY; Chen C; Chen WQ; Gao YX; Li LB; Cheng KL; Qian JM; Wang L; Li JN
BMC Gastroenterol; 2019 Dec; 19(1):226. PubMed ID: 31881948
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea.
Kim DH; Cha JM; Shin HP; Joo KR; Lee JI; Park DI
J Clin Gastroenterol; 2015 Jan; 49(1):41-9. PubMed ID: 24583751
[TBL] [Abstract][Full Text] [Related]
17. Fecal immunochemical testing results and characteristics of colonic lesions.
van Doorn SC; Stegeman I; Stroobants AK; Mundt MW; de Wijkerslooth TR; Fockens P; Kuipers EJ; Bossuyt PM; Dekker E
Endoscopy; 2015 Nov; 47(11):1011-7. PubMed ID: 26126163
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary application of the Asia-Pacific colorectal screening score combined with the quantitative fecal occult blood in colorectal neoplasia screening].
Kang Q; Li N; Wang RF; Yang L; Jin P; Sheng JQ
Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3825-3828. PubMed ID: 34895425
[TBL] [Abstract][Full Text] [Related]
19. First-degree relatives of colorectal cancer patients are likely to show advanced colorectal neoplasia despite a negative fecal immunochemical test.
Cha JM; Lee JI; Joo KR; Shin HP; Park JJ; Jeun JW; Lim JU
Digestion; 2012; 86(4):283-7. PubMed ID: 23051697
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
